EUVIMEDEUVIMED entdecken
Open Access

Incidence and window period residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2017 to 2023: The transfusion‐transmissible infections monitoring system

Emilya Huseynova iD, James Haynes, Edward P Notari, Brian Custer, Rita Reik, Jed Gorlin, Artur Belov iD, Benyam Hailu, Barbee Whitaker, Roger Y Dodd, Susan L Stramer

Transfusion · 2025-10 · 65 (10) · 1876-1887

DOI: 10.1111/trf.18398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, online erschienen am 07.09.2025. Verfasst von Emilya Huseynova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Transfusion Safety and Surveillance, American Red Cross, Rockville, Maryland, USA. Hauptthemen laut MEDLINE: Blood Donors, HIV Infections, Hepatitis C, Hepatitis B. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: U.S. Food and Drug Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Transfusion‐Transmissible Infections Monitoring System assesses trends in ~60% of the US blood supply. Donors with high‐risk behaviors, including injection drug use, men having sex with other men, or exchanging sex for money/drugs were deferred for 12 months (12M) from 2016 to 2020 and 3 months (3M) from 2020 to 2023. Here we evaluate HIV, HBV, and HCV incidence and window‐period residual risk (WPRR) in two ~3‐year periods of 12M (2017–2020) and 3M (2020–2023) to identify any differences.

Methods

First‐time (FT), repeat (RPT), and overall weighted incidence/100,000 person‐years (phtpy) for HIV, HBV, and HCV were estimated based on serology and nucleic acid test results. WPRR was calculated by multiplying respective incidence by agent‐specific WP. Fisher's exact test evaluated incidence changes between the two periods ( α = 0.05).

Results

Overall weighted incidence for HIV, HBV, and HCV was 2.22, 1.59, and 0.53 phtpy versus 1.03, 0.93, and 0.16 phtpy in 12M and 3M periods, respectively. Overall WPRR per 1,000,000 donations for HIV, HBV, and HCV was 0.45, 0.63, and 0.53 versus 0.23, 0.43, and 0.16 in 12M and 3M periods, respectively. All comparisons by agent and by period were significant ( p < .01).

Conclusions

Despite reducing donor deferral periods for many infectious risk behaviors, HIV, HBV, and HCV overall incidence declined from the 12M to 3M periods. WPRR also declined from 12M to 3M, remaining under 1 per 2,000,000 donations in the 3M period. Thus, changes in policy did not adversely impact the safety of the blood supply with respect to the major infectious disease agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood DonorsHIV InfectionsHepatitis CHepatitis BTransfusion ReactionHumansIncidenceUnited StatesMaleFemaleHepacivirusHepatitis B virusBlood SafetyAdultBlood Donation

Autor:innen und Institutionen

  • Transfusion Safety and Surveillance, American Red Cross, Rockville, Maryland, USA.
  • Department of Epidemiology, Vitalant Research Institute, San Francisco, California, USA.
  • OneBlood, St. Petersburg, Florida, USA.
  • Physician Services, New York Blood Center Enterprises, New York, New York, USA.
  • Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • National Heart, Lung, and Blood Institute, US National Institutes of Health, Bethesda, Maryland, USA.

ORCID-Profile: Emilya Huseynova, Artur Belov

Förderung

  • U.S. Food and Drug Administration

Zitieren

APA

Huseynova, E., Haynes, J., Notari, E. P., Custer, B., Reik, R., Gorlin, J., Belov, A., Hailu, B., Whitaker, B., Dodd, R. Y., & Stramer, S. L. (2025). Incidence and window period residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2017 to 2023: The transfusion‐transmissible infections monitoring system. Transfusion, 65(10), 1876-1887. https://doi.org/10.1111/trf.18398

Vancouver

Huseynova E, Haynes J, Notari EP, Custer B, Reik R, Gorlin J, et al. Incidence and window period residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2017 to 2023: The transfusion‐transmissible infections monitoring system. Transfusion. 2025;65(10):1876-1887. doi:10.1111/trf.18398

BibTeX
@article{Huseynova2025,
  author = {Huseynova, Emilya and Haynes, James and Notari, Edward P and Custer, Brian and Reik, Rita and Gorlin, Jed and Belov, Artur and Hailu, Benyam and Whitaker, Barbee and Dodd, Roger Y and Stramer, Susan L},
  title = {Incidence and window period residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2017 to 2023: The transfusion‐transmissible infections monitoring system},
  journal = {Transfusion},
  year = {2025},
  volume = {65},
  number = {10},
  pages = {1876--1887},
  doi = {10.1111/trf.18398}
}
Kostenlos starten →